News

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.

An international collaboration has advanced therapies for co-occurring substance use disorders and PTSD and helped to inform prevention efforts globally.

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

MUSC hosts a New Faculty Research Orientation, providing faculty with essential resources and insights to excel.

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

Electronic health record-based screening for intimate partner violence prioritizes confidentiality.

Using a novel model for a common fatty liver disease, an MUSC team has identified a pathway that could be targeted to reduce fat accumulation in the liver.

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.